Evaluation of an educational conference for persons affected by hereditary frontotemporal degeneration and amyotrophic lateral sclerosis
PEC Innovation, ISSN: 2772-6282, Vol: 2, Page: 100108
2023
- 3Citations
- 11Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations3
- Citation Indexes3
- CrossRef2
- Captures11
- Readers11
- 11
- Mentions1
- News Mentions1
- News1
Most Recent News
Johns Hopkins University Researchers Detail New Studies and Findings in the Area of Amyotrophic Lateral Sclerosis (Evaluation of an educational conference for persons affected by hereditary frontotemporal degeneration and amyotrophic lateral ...)
2023 DEC 11 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Daily News -- Researchers detail new data in
Article Description
There are limited studies exploring the support and education needs of individuals at-risk for or diagnosed with hereditary frontotemporal degeneration (FTD) and/or amyotrophic lateral sclerosis (ALS). This study evaluated a novel conference for this population to assess conference efficacy, probe how participants assessed relevant resources, and identify outstanding needs of persons at-risk/diagnosed. We implemented a post-conference electronic survey that probed participants' satisfaction, prior experience with resources, and unmet needs. Along with multiple-choice, free-text items were included to gather qualitative context. Survey completion rate was 31% (115/376 attendees who were emailed the survey). There was positive interest in pursuing genetic counseling among eligible responders: 61% indicated they planned to seek genetic counseling because of the conference, which was significantly more than those who were undecided (21%) or did not plan to seek genetic counseling (18%). Qualitative data demonstrated need for additional education, support, and research opportunities. Conference reactions indicate this is a valued resource. Results indicated the importance of raising awareness about existing resources, and the need for further resource development, especially for at-risk communities. While most resources are developed for caregivers' needs, this unique program targets at-risk individuals and unites ALS and FTD communities.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2772628222000930; http://dx.doi.org/10.1016/j.pecinn.2022.100108; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85152553284&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/37214502; https://linkinghub.elsevier.com/retrieve/pii/S2772628222000930; https://dx.doi.org/10.1016/j.pecinn.2022.100108
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know